Astex Pharmaceuticals

Astex Pharmaceuticals

Astex Pharmaceuticals™ is a leader in innovative drug discovery, development and commercialization, committed to the fight against cancer and other life-threatening diseases.

-
Telephone: +44 (0)1223 226 200
Email:
Fax: +44 (0)1223 226 201
Address:
Postcode:
Country:
Website: http://www.astx.com
Membership type:Corporate 51+ (£1,000+VAT pa)

Innovative Discovery
Enhanced Opportunities

Astex Pharmaceuticals™ is a leader in innovative drug discovery, development and commercialization, committed to the fight against cancer and other life-threatening diseases.

Oncology Focused

We are a leader in innovative small-molecule therapeutics with particular expertise in fragment-based drug discovery, the most important advance in discovery chemistry in the last 20 years. Our primary areas of focus are oncology and hematology.

Financially Strong

We are a publicly traded pharmaceutical company with strong cash reserves and royalty revenues from the sales of our product DACOGEN®. In addition, our partnerships could deliver future product milestones plus royalties.

Dementia Consortium signs new pharma partner Astex Pharmaceuticals

The Dementia Consortium, a unique charity-private partnership, today announced Astex Pharmaceuticals as a new member.

12 October 2015Read in full

Cancer Research and Astex join forces to trial potential new cancer treatments

Cancer Research UK's Drug Development Office (DDO) has announced that Astex Pharmaceuticals will join its Experimental Cancer Medicine Centre (ECMC) Combinations Alliance with an aim to develop new cancer treatments.

16 May 2014Read in full